{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T23:12:21Z","timestamp":1775517141165,"version":"3.50.1"},"reference-count":67,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.medmal.2009.02.038","type":"journal-article","created":{"date-parts":[[2009,6,5]],"date-time":"2009-06-05T05:14:40Z","timestamp":1244178880000},"page":"483-492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Pharmacodynamie des antibiotiques dans le LCR\u00a0: principes et cons\u00e9quences (facteurs pr\u00e9dictifs d\u2019efficacit\u00e9)"],"prefix":"10.1016","volume":"39","author":[{"given":"F.","family":"Van Bambeke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.M.","family":"Tulkens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medmal.2009.02.038_bib1","series-title":"Principles and practice of infectious diseases","first-page":"271","article-title":"Pharmacokinetics and pharmacodynamics of anti-infective agents","author":"Amsden","year":"2005"},{"key":"10.1016\/j.medmal.2009.02.038_bib2","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0891-5520(05)70094-5","article-title":"Models of experimental bacterial meningitis. Role and limitations","volume":"13","author":"Koedel","year":"1999","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.medmal.2009.02.038_bib3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0891-5520(05)70096-9","article-title":"Pharmacokinetics and pharmacodynamics of antibiotics in meningitis","volume":"13","author":"Andes","year":"1999","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.medmal.2009.02.038_bib4","series-title":"Neuro-infectiologie","first-page":"355","article-title":"M\u00e9dicaments anti-infectieux dans les pathologies infectieuses du SNC","author":"Van Bambeke","year":"2002"},{"key":"10.1016\/j.medmal.2009.02.038_bib5","first-page":"173","article-title":"Pharmacodynamics of antibiotics in experimental bacterial meningitis\u2013two sides to rapid bacterial killing in the cerebrospinal fluid","volume":"74","author":"Tauber","year":"1990","journal-title":"Scand J Infect Dis Suppl"},{"key":"10.1016\/j.medmal.2009.02.038_bib6","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1128\/AAC.43.4.876","article-title":"Pharmacodynamics of vancomycin for the treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis","volume":"43","author":"Ahmed","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.038_bib7","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0733-8619(05)70171-7","article-title":"The penetration of anti-infectives into the central nervous system","volume":"17","author":"Kearney","year":"1999","journal-title":"Neurol Clin"},{"key":"10.1016\/j.medmal.2009.02.038_bib8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0022-510X(94)90052-3","article-title":"Lipophilicity at pH 7.4 and molecular size govern the entry of the free serum fraction of drugs into the cerebrospinal fluid in humans with uninflamed meninges","volume":"122","author":"Nau","year":"1994","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.medmal.2009.02.038_bib9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2165\/00003088-199835030-00005","article-title":"Pharmacokinetic optimisation of the treatment of bacterial central nervous system infections","volume":"35","author":"Nau","year":"1998","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.medmal.2009.02.038_bib10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1472-8206.1996.tb00311.x","article-title":"Influence of lipophilicity on the diffusion of cephalosporins into the cerebrospinal fluid","volume":"10","author":"Radouane","year":"1996","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.medmal.2009.02.038_bib11","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2165\/00003088-200039050-00003","article-title":"Pharmacokinetics and pharmacodynamics of cephalosporins in cerebrospinal fluid","volume":"39","author":"Lutsar","year":"2000","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.medmal.2009.02.038_bib12","first-page":"42","article-title":"Rationale for clinical trials evaluating ceftriaxone in the therapy of bacterial meningitis","volume":"77","author":"Scheld","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/j.medmal.2009.02.038_bib13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0006-2952(00)00291-4","article-title":"Antibiotic efflux pumps","volume":"60","author":"Van Bambeke","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.medmal.2009.02.038_bib14","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/jac\/dkg225","article-title":"Antibiotic efflux pumps in eukaryotic cells: occurrence and impact on antibiotic cellular pharmacokinetics, pharmacodynamics and toxicodynamics","volume":"51","author":"Van Bambeke","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2009.02.038_bib15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0169-409X(02)00172-2","article-title":"Drug efflux transporters in the CNS","volume":"55","author":"Sun","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.medmal.2009.02.038_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.canlet.2006.12.023","article-title":"The role of membrane transporters in drug delivery to brain tumors","volume":"254","author":"Nies","year":"2007","journal-title":"Cancer Lett"},{"key":"10.1016\/j.medmal.2009.02.038_bib17","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/515003","article-title":"Antibiotic pharmacodynamics in cerebrospinal fluid","volume":"27","author":"Lutsar","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.038_bib18","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.medmal.2006.07.013","article-title":"Mutation window for the \u201cpneumococcus-fluoroquinolone\u201d couple. Contribution of experimental models","volume":"36","author":"Chavanet","year":"2006","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.medmal.2009.02.038_bib19","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1055\/s-2007-996405","article-title":"Optimizing use of quinolones in the critically ill","volume":"28","author":"Yang","year":"2007","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.medmal.2009.02.038_bib20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1469-0691.2006.01492.x","article-title":"The emergence of antibiotic resistance by mutation","volume":"13","author":"Woodford","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.medmal.2009.02.038_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkn312","article-title":"Antimicrobial activity of cefepime and rifampicin in cerebrospinal fluid in vitro","author":"Sauermann","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2009.02.038_bib22","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1128\/AAC.48.10.3670-3676.2004","article-title":"Pharmacodynamic functions: a multiparameter approach to the design of antibiotic treatment regimens","volume":"48","author":"Regoes","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.038_bib23","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/jac\/dkl489","article-title":"Combined effect of pH and concentration on the activities of gentamicin and oxacillin against Staphylococcus aureus in pharmacodynamic models of extracellular and intracellular infections","volume":"59","author":"Baudoux","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2009.02.038_bib24","first-page":"598","article-title":"Continuous infusion of beta-lactams","volume":"13","author":"Mouton","year":"2007","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.medmal.2009.02.038_bib25","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0891-5520(03)00065-5","article-title":"Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid","volume":"17","author":"Craig","year":"2003","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.medmal.2009.02.038_bib26","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1469-0691.2005.01131.x","article-title":"Quinolones in 2005: an update","volume":"11","author":"Van Bambeke","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.medmal.2009.02.038_bib27","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1128\/AAC.36.12.2577","article-title":"Continuous infusion of beta-lactam antibiotics","volume":"36","author":"Craig","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.038_bib28","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/jac\/dkm467","article-title":"Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection","volume":"61","author":"De Jongh","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2009.02.038_bib29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijantimicag.2007.02.002","article-title":"Continuous infusion of beta-lactam antibiotics in severe infections: a review of its role","volume":"30","author":"Roberts","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.medmal.2009.02.038_bib30","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1128\/AAC.46.8.2327-2332.2002","article-title":"Comparative stability studies of antipseudomonal beta-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units)","volume":"46","author":"Viaene","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.038_bib31","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1592\/phco.24.8.803.36070","article-title":"Meropenem administered as a prolonged infusion to treat serious gram-negative central nervous system infections","volume":"24","author":"Capitano","year":"2004","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.medmal.2009.02.038_bib32","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1468-1331.2008.02193.x","article-title":"EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS task force on acute bacterial meningitis in older children and adults","volume":"15","author":"Chaudhuri","year":"2008","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.medmal.2009.02.038_bib33","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijantimicag.2007.09.009","article-title":"Linezolid pharmacokinetic\/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion","volume":"31","author":"Adembri","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.medmal.2009.02.038_bib34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2165\/00148581-200608020-00005","article-title":"Pharmacodynamic evaluation of meropenem and cefotaxime for pediatric meningitis: a report from the OPTAMA program","volume":"8","author":"Ellis","year":"2006","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.medmal.2009.02.038_bib35","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.diagmicrobio.2007.03.015","article-title":"Comparison of the probability of target attainment between ceftriaxone and cefepime in the cerebrospinal fluid and serum against Streptococcus pneumoniae","volume":"58","author":"Lodise","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.038_bib36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1469-0691.2006.01617.x","article-title":"The contribution of pharmacokinetic-pharmacodynamic modelling with Monte Carlo simulation to the development of susceptibility breakpoints for Neisseria meningitidis","volume":"13","author":"Burgess","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.medmal.2009.02.038_bib37","series-title":"Pharmacotherapy principles and practice","first-page":"1033","article-title":"Central nervous system infections","author":"Goodwin","year":"2008"},{"key":"10.1016\/j.medmal.2009.02.038_bib38","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2165\/00003495-200868020-00003","article-title":"Treatment options for multidrug-resistant Acinetobacter species","volume":"68","author":"Gilad","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.medmal.2009.02.038_bib39","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1592\/phco.27.2.227","article-title":"Emerging options for treatment of invasive, multidrug-resistant Staphylococcus aureus infections","volume":"27","author":"Drew","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.medmal.2009.02.038_bib40","doi-asserted-by":"crossref","first-page":"456","DOI":"10.5144\/0256-4947.2007.456","article-title":"Multidrug resistant Acinetobacter nosocomial meningitis treated successfully with parenteral tigecycline","volume":"27","author":"Wadi","year":"2007","journal-title":"Ann Saudi Med"},{"key":"10.1016\/j.medmal.2009.02.038_bib41","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/jac\/dkl007","article-title":"Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis","volume":"57","author":"Gerber","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2009.02.038_bib42","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1128\/AAC.48.10.3928-3933.2004","article-title":"Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis","volume":"48","author":"Cottagnoud","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.038_bib43","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1086\/590257","article-title":"Successful treatment of methicillin-resistant Staphylococcus aureus meningitis with daptomycin","volume":"47","author":"Lee","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.038_bib44","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1128\/AAC.01139-07","article-title":"Activity of daptomycin against Listeria monocytogenes isolates from cerebrospinal fluid","volume":"52","author":"Spanjaard","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.038_bib45","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1345\/aph.1H307","article-title":"Linezolid for the treatment of patients with central nervous system infection","volume":"41","author":"Ntziora","year":"2007","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.medmal.2009.02.038_bib46","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.2146\/ajhp070080","article-title":"Telavancin: a novel lipoglycopeptide antimicrobial agent","volume":"64","author":"Attwood","year":"2007","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.medmal.2009.02.038_bib47","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.2165\/00003495-200767070-00006","article-title":"Comparative review of the carbapenems","volume":"67","author":"Zhanel","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.medmal.2009.02.038_bib48","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.rmed.2007.06.030","article-title":"Prevention of bacterial meningitis: an overview of Cochrane systematic reviews","volume":"101","author":"Prasad","year":"2007","journal-title":"Respir Med"},{"key":"10.1016\/j.medmal.2009.02.038_bib49","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/jac\/dkn110","article-title":"Pharmacokinetics of moxifloxacin in non-inflamed cerebrospinal fluid of humans: implication for a bactericidal effect","volume":"61","author":"Kanellakopoulou","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2009.02.038_bib50","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1128\/AAC.41.11.2414","article-title":"Pharmacodynamics and bactericidal activity of ceftriaxone therapy in experimental cephalosporin-resistant pneumococcal meningitis","volume":"41","author":"Lutsar","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.038_bib51","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2165\/00003088-200039030-00002","article-title":"Comparative pharmacokinetics of the carbapenems: clinical implications","volume":"39","author":"Mouton","year":"2000","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.medmal.2009.02.038_bib52","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1128\/AAC.47.6.1943-1947.2003","article-title":"Activities of ertapenem, a new long-acting carbapenem, against penicillin-sensitive or -resistant pneumococci in experimental meningitis","volume":"47","author":"Cottagnoud","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.038_bib53","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/jac\/dkn080","article-title":"Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy","volume":"62","author":"Ingram","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2009.02.038_bib54","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1128\/AAC.42.7.1706","article-title":"Evaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin-resistant pneumococcus in rabbits","volume":"42","author":"Ostergaard","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.038_bib55","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1128\/AAC.01211-07","article-title":"Comparison of the in vitro efficacies of moxifloxacin and amoxicillin against Listeria monocytogenes","volume":"52","author":"Grayo","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.038_bib56","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1128\/AAC.00177-08","article-title":"Rapid eradication of Listeria monocytogenes by moxifloxacin in a murine model of central nervous system listeriosis","volume":"52","author":"Grayo","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.038_bib57","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1128\/AAC.46.7.2095-2103.2002","article-title":"Comparative intracellular (THP-1 macrophage) and extracellular activities of beta-lactams, azithromycin, gentamicin, and fluoroquinolones against Listeria monocytogenes at clinically relevant concentrations","volume":"46","author":"Carryn","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.038_bib58","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1128\/AAC.41.1.49","article-title":"Once-daily gentamicin therapy for experimental Escherichia coli meningitis","volume":"41","author":"Ahmed","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.038_bib59","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s10096-007-0324-2","article-title":"Flucloxacillin treatment of Staphylococcus aureus meningitis","volume":"26","author":"Ritchie","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.038_bib60","first-page":"25","article-title":"Neurologic manifestations of Staphylococcus aureus infections. Analysis of 43\u00a0patients","volume":"145","author":"Schafer","year":"1994","journal-title":"Schweiz Arch Neurol Psychiatr"},{"key":"10.1016\/j.medmal.2009.02.038_bib61","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1128\/AAC.00051-06","article-title":"Serum and cerebrospinal fluid concentrations of linezolid in neurosurgical patients","volume":"50","author":"Myrianthefs","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.038_bib62","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s15010-007-6211-z","article-title":"Treatment of meningitis caused by methicillin-resistant Staphylococcus aureus with linezolid","volume":"35","author":"Kessler","year":"2007","journal-title":"Infection"},{"key":"10.1016\/j.medmal.2009.02.038_bib63","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1080\/00365540410019345","article-title":"Successful treatment of disseminated cerebritis complicating methicillin-resistant Staphylococcus aureus. Endocarditis unresponsive to vancomycin therapy with linezolid","volume":"36","author":"Pistella","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.038_bib64","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3171\/JNS-07\/09\/0651","article-title":"Successful treatment of methicillin-resistant Staphylococcus aureus meningitis using linezolid without removal of intrathecal infusion pump. Case report","volume":"107","author":"Kallweit","year":"2007","journal-title":"J Neurosurg"},{"key":"10.1016\/j.medmal.2009.02.038_bib65","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1445-5994.2008.01650.x","article-title":"Cavernous sinus thrombosis and meningitis from community-acquired methicillin-resistant Staphylococcus aureus infection","volume":"38","author":"Munckhof","year":"2008","journal-title":"Intern Med J"},{"key":"10.1016\/j.medmal.2009.02.038_bib66","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1476-0711-7-11","article-title":"An uncommon presentation for a severe invasive infection due to methicillin-resistant Staphylococcus aureus clone USA300 in Italy: a case report","volume":"7","author":"Valentini","year":"2008","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.medmal.2009.02.038_bib67","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.micinf.2006.12.013","article-title":"Evaluation of antimicrobial regimens in a guinea-pig model of meningitis caused by Pseudomonas aeruginosa","volume":"9","author":"Maiques","year":"2007","journal-title":"Microbes Infect"}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X09001127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X09001127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:06:53Z","timestamp":1759972013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X09001127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":67,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0399077X09001127"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2009.02.038","relation":{},"ISSN":["0399-077X"],"issn-type":[{"value":"0399-077X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacodynamie des antibiotiques dans le LCR\u00a0: principes et cons\u00e9quences (facteurs pr\u00e9dictifs d\u2019efficacit\u00e9)","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2009.02.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}